Shares in the Hydroponics Company soared after it announced its subsidiary Canndeo has been granted a licence to grow medicinal cannabis in Australia.
At the close, the shares were up 42% to $0.32.
The company says the licence from the Australian Government’s Office of Drug Control is an important step to becoming a legal domestic source of cannabis for medicinal use.
“It is a major step in the transition of the company towards commercial supply and monetisation of the opportunity that exists in the medicinal cannabis market,” says CEO David Radford.
Australian created new laws in October last year to allow the cultivation, production and manufacturing of medicinal cannabis products in Australia.